Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
49.20    0.00 (0.00%)
Bid:
48.40
Ask:
50.00
Spread: 1.60 (3.306%)
Market Cap: £188.87m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Holding in Sarian Systems Ltd

29 Apr 2008 09:08

British SmallerTechCompaniesVCT2PLC29 April 2008 British Smaller Technology Companies VCT 2 plc ("the Company") Announcement in respect of holding in Sarian Systems Ltd The Company held 2,202 shares in Sarian Systems Ltd representing approximately17.3% of that company's fully diluted issued share capital. Yesterday DigiInternational Inc, a Company quoted on Nasdaq, announced the acquisition ofSarian Systems in a cash transaction for approximately $30.5m. This transaction has resulted in a cash receipt of approximately £2.6m for theCompany compared to a carrying value of £1.3m which was incorporated within thenet asset value of British Smaller Technology Companies VCT 2 plc at 31 December2007. Consequently the effect of this transaction had it been incorporated intothe accounts at 31 December 2007 would have been to have increased the Company'snet asset value per share from 79.0 pence per share to 86.7 pence per share, anincrease of 9.7%. The impact on the total return, calculated by reference to the net asset valueper share and cumulative dividends paid, would have been to have increased thetotal return at 31 December 2007 from 89.5 pence per share to 97.2 pence pershare. In conformity with the Transparency Directive's transitional provision 6, theCompany notifies the market of the following: The Company's issued share capital consists of 16,641,257 Ordinary Shares withvoting rights. Therefore, the total number of voting rights is 16,641,257. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in the Company under the FSA'sDisclosure and Transparency Rules. 29 April 2008 End For further details, please contact: David Hall, YFM Private Equity Tel: 0161 832 7603 Johnathan Becher, Landsbanki Limited Tel: 0207 426 3269 Michael Bellamy, Landsbanki Limited Tel: 0207 426 9547 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Nov 20241:52 pmRNSResult of General Meeting
1st Nov 202411:04 amRNSPayment of Dividend and Allotment of Shares
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update
24th Oct 20249:00 amRNSUpdate on Offers
24th Oct 20249:00 amRNSUpdate on Offers
17th Oct 20241:00 pmRNSPublication of Circular
17th Oct 202412:45 pmRNSPublication of a Prospectus
17th Oct 202412:45 pmRNSPublication of a Prospectus
27th Sep 20247:34 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSHalf-year Report
10th Sep 20242:00 pmRNSUpdate on new combined offer for subscription
20th Aug 20247:00 amRNSStatement re NAV and Proposed Fundraising
20th Aug 20247:00 amRNSStatement re NAV and Proposed Fundraising
28th Jun 20249:43 amRNSPayment of dividend and issue of shares
25th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 202412:30 pmRNSInterim Management Statement
13th Jun 202410:03 amRNSResult of AGM
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
13th Dec 20234:00 pmRNSOffer Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.